Q3 2017 Holdings
Filed 2017-11-14 | 51 holdings | $22.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $14.2M | 550,000 | 62.0% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $3.2M | 572,738 | 14.0% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $3.1M | 300,000 | 13.7% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $1.8M | 100,000 | 7.9% |
| Myokardia Inc | COM | 62857M105 | $45.9K | 1,071,889 | 0.2% |
| Ignyta Inc | COM | 451731103 | $43.2K | 3,500,000 | 0.2% |
| Omeros Corp(OMER) | COM | 682143102 | $36.8K | 1,700,000 | 0.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $35.0K | 1,000,000 | 0.2% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $32.5K | 950,000 | 0.1% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $27.0K | 500,000 | 0.1% |
| G1 Therapeutics, Inc.(GTHXEUR) | COM | 3621LQ109 | $22.3K | 897,505 | 0.1% |
| Bluebird BIO Inc | COM | 09609G100 | $18.9K | 137,500 | 0.1% |
| Quotient LTD | SHS | G73268107 | $17.2K | 3,485,921 | 0.1% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $17.0K | 1,940,880 | 0.1% |
| Juno Therapeutics Inc | COM | 48205A109 | $16.8K | 375,000 | 0.1% |
| Omeros Corp | CALL | 682143902 | $16.2K | 750,000 | 0.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $15.3K | 250,000 | 0.1% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $12.1K | 388,574 | 0.1% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $11.9K | 200,000 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $11.7K | 1,000,000 | 0.1% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $11.1K | 900,000 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $11.0K | 900,000 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $9.2K | 570,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $9.1K | 100,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $9.1K | 323,545 | 0.0% |
| ZAI Labs LTD(ZLAB) | ADR | 98887Q104 | $9.0K | 333,166 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $8.8K | 500,000 | 0.0% |
| Proteostasis Therapeutics in | COM | 74373B109 | $8.0K | 3,804,027 | 0.0% |
| Gemphire Therapeutics Inc | COM | 36870A108 | $7.6K | 800,000 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $7.2K | 809,804 | 0.0% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $6.8K | 400,000 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $6.0K | 400,000 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $5.6K | 359,738 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $5.6K | 1,250,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $5.2K | 75,000 | 0.0% |
| Mersana Therapeutics | COM | 59045L106 | $5.1K | 295,549 | 0.0% |
| Advanced Accelerator Applic | SPONSORED ADS | 00790T100 | $5.1K | 75,000 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $4.6K | 607,903 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $4.4K | 202,079 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $4.4K | 296,296 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $4.0K | 500,000 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $3.9K | 3,550,000 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $3.1K | 600,000 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $2.9K | 280,500 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $2.8K | 75,000 | 0.0% |
| Ovid Therapeutics Inc.(OVID) | COM | 690469101 | $1.9K | 223,972 | 0.0% |
| Curis Inc | COM | 231269101 | $1.7K | 1,150,000 | 0.0% |
| Oncobiologics Inc | COM | 68235M105 | $814 | 593,883 | 0.0% |
| Oncobiologics Inc | *W EXP 02/18/201 | 68235M113 | $51 | 416,666 | 0.0% |
| Oncobiologics Inc | *W EXP 05/18/201 | 68235M121 | $21 | 416,666 | 0.0% |